DHL SERVICES LIMITED
Company number 03324664 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Score: B (Provisional – Compliance and Structural Indicators Only)
This grade reflects the administrative and corporate indicators available in the data, not a full financial assessment. The company is active, its accounts and confirmation statement are up to date with no overdue filings, and it has been incorporated since 1997, suggesting an established entity. However, no profit, loss, asset, liability, or cash flow figures were provided, so profitability, liquidity, and solvency cannot be scored. The grade should be treated as a “temperature and pulse” reading: normal on compliance, but with key blood tests still missing.
Key Vital Signs
| Indicator | Reading | Interpretation |
|---|---|---|
| Company status | Active | The company is registered and not in liquidation, administration, or receivership. Equivalent to a stable heartbeat. |
| Filing compliance | No overdue accounts or returns | Accounts last made up to 31 December 2025; next due 30 September 2027. Confirmation statement last made up to 6 September 2026; next due 20 September 2027. This is like normal blood pressure—no immediate signs of administrative distress. |
| Company age | Incorporated 26 February 1997 | Approximately 28 years of continuous registration. An established entity with a long track record. |
| Share capital | £1,000 | Nominal capital only. This is a legal formality and does not indicate financial strength or cash reserves. |
| Corporate ownership | DHL Supply Chain Limited owns more than 75% of shares | A single corporate person with significant control holds the majority interest. This may imply access to group resources, but also means the company’s fortunes are closely tied to its parent. |
| Business activity | SIC 82990 – Other business support service activities | A support services classification; no financial performance insight can be drawn from the code alone. |
| Board changes | Several directors resigned during 2026 | Changes in directorship are common and not inherently a symptom of distress, but they warrant monitoring alongside future filings. |
Missing vital signs: The data provided does not include turnover, gross or net profit, fixed assets, current assets, current liabilities, net current assets, net assets, shareholders’ funds, or cash flow. Without these figures, I cannot calculate liquidity, solvency, or profitability ratios.
Diagnosis
Based on the available information, the company presents as administratively healthy but financially opaque.
- Positive indicators: Active status, up-to-date filings, long incorporation history, and majority ownership by a corporate entity suggest structural stability and potential group backing.
- Limitations: The nominal share capital of £1,000 provides no cushion or indication of invested funds. The absence of any income statement or balance sheet data means there is no evidence of whether the company is generating profit, meeting its obligations as they fall due, or holding sufficient liquid resources.
- Watch items: Multiple director resignations in 2026 should be monitored in context. On their own, they are not a symptom of financial illness, but a sudden exodus can sometimes accompany broader strategic or operational changes.
Overall, there is no evidence of insolvency or filing distress, but there is also no evidence of financial performance. The company’s true health cannot be confirmed without reviewing the filed accounts for the year ended 31 December 2025.
Prognosis
The short-term outlook is stable from a compliance perspective, assuming the company continues to meet its filing obligations and retains the support of its controlling corporate shareholder. The longer-term financial outlook is indeterminate until the underlying accounts are examined. If the filed accounts reveal consistent profitability, positive net assets, and adequate working capital, the prognosis would be favourable. If they reveal losses, negative net assets, or creditor pressure, the outlook would require closer scrutiny.
Recommendations
- Obtain the full annual accounts for the year ended 31 December 2025 from Companies House. These are the essential “blood tests” needed to complete the diagnosis.
- Calculate core financial ratios once the accounts are available: current ratio (current assets ÷ current liabilities), net profit margin, interest cover, and gearing (debt ÷ equity).
- Assess working capital by reviewing net current assets to determine whether the company can meet short-term obligations.
- Confirm parent company support by reviewing any guarantees, letters of comfort, or group financing arrangements mentioned in the accounts.
- Monitor forthcoming deadlines: accounts are due by 30 September 2027 and the confirmation statement by 20 September 2027. Timely filing will maintain the current clean compliance record.
- Track director and PSC changes in subsequent filings to understand whether recent resignations are part of routine succession or a broader shift.